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Introduction

Figure 2: β-catenin staining during lens regeneration in dorsal and ventral iris.

Newts have an exceptional capability of regenerating an
entire organ via transdifferrentiation. Of particular interest is
their ability to regenerate the lens from iris pigment epithelial
cells (PEC). Interesting enough, this ability to regenerate
lens from the iris is a highly topological process, meaning
that the lens will always form from the dorsal iris and never
from the ventral. Thus, differences in gene expression of
dorsal versus ventral iris have been suggested aid in finding
the mechanism of lens regeneration. This implies that the
regeneration process is controlled by the action of spatial
organized signaling systems and different signaling pathways
must be studied for better understanding. The Wnt/ β-catenin
signaling pathway represents one of the major pathways that
was demonstrated to play a role in dorsal iris
transdifferentiation (Figure 1 below).

Figure 3: Hematoxylin and eosin staining of crosssections of newt eyes at day 20 post-lentectomy

Figure 4: β-catenin staining in retina during lens
regeneration.

Conclusion

Methods
Following lens removal, newts were treated with the corresponding Wntrelated drugs (Wnt activator agonist 681665, GSK3 alpha/beta inhibitor
CHIR 99021, β-catenin/TCF inhibitor FH535) at 1, 10 and 25 microM
concentration in 30 microliter 0.1%DMSO/0.6% NaCl by intra-peritoneal
injection for the complete time period of 20 days. Controls animals were
treated with 0.1%DMSO/0.6% NaCl solution. Following 20 days of lens
regeneration,
eyes
were
dissected
and
fixed
in
4%
paraformaldehyde/phosphate buffer saline followed by histology analysis.
Histology analysis included paraffin embedding of eye specimen followed
by sectioning. Sections were deparaffinized and stained using
Hematoxylin/Eosin staining.
In addition eyes from untreated newts were obtain in 0, 8,9,10,11,12,13,14
and 22 days post lentectomy for immunohistochemistry. Those sections
were stained with a β-catenin antibody in order to observe if the antibody
is present in the nucleus of the iris (Figure 2) or the retina (Figure 4).

Wnt activator 681665 was first used to increase
beta catenin concentration in the nucleus in order
to turn the pathway “ON” in the ventral iris and
develop an additional lens. The Wnt activator
681665 was hypothesized to bind in the membrane
receptor Frizzled (Fzd) and inhibit the formation of
the beta-catenin destruction complex in the
cytoplasm. Lens expression was observed only
from the dorsal iris (Figure 3A). Then CHIR 999021
was used in order to inhibit the GSK-3 kinase
which phosphorylates beta-catenin leading to its
degradation. The results showed only dorsal irisderived lens development (Figure 3B). Lastly
FH535 was used in order to inhibit the beta-catenin
in the nucleus and thus inhibit any lens formation
from both dorsal and ventral iris. The results were
again lens formation from the dorsal iris (Figure
3c).
After staining with beta-catenin antibody it was found
that the protein was found in both dorsal and ventral iris
nucleus from day 0 till day13 (Figure 2). Thus, the
original hypothesis that Wnt pathway is in the “ON”
state in the dorsal and “OFF” state in the ventral iris
was disproved, since beta-catenin was present in both
side of the iris indicating the “ON” state.
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